All lobbying filings

AVENUE SOLUTIONS

Lobbying for SIEMENS MEDICAL SOLUTIONS USA, INC. · Healthcare diagnostics

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$70,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues related to healthcare data privacy; Issues related to Artificial Intelligence within the healthcare sector; H.R. 6197/S. 1399, Health Tech Investment Act

Medicare/Medicaid

Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process; S. 1399, Health Tech Investment Act

Trade (domestic/foreign)

Issues related to medical supply chains and procurement

Bills named in this filing 4

H.R. 6197
Health Tech Investment Act
S. 1399
Health Tech Investment Act
H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.